Gene Editing, In-Vitro and In-Vivo - Clinical Research Informer

Could CRISPR cure HIV? US biotech Excision raises $60m to find out

pharmaphorum

FEBRUARY 19, 2021

Snipping out this viral code with powerful CRISPR gene editing technology, which last year won Drs Emmanuelle Charpentier and Jennifer Doudna the Nobel Prize for chemistry, would in theory prevent the need for drugs to suppress the virus and the development of AIDS.

Gene Editing

Gene Editing In-Vivo DNA In-Vitro

The Challenges and Promise of CAR T-Cell Therapy in Oncology

XTalks

SEPTEMBER 20, 2024

Vittoria Biotherapeutics is a clinical-stage cell therapy company that incorporates the latest advancements in cell therapy and gene editing with a unique approach that potentially overcomes some of the issues with this therapeutic modality. Its therapeutic pipeline targets unmet needs in oncology and autoimmune disease.

Gene Editing

Gene Editing Manufacturing Gene In-Vivo

Clinical Research Informer

Could CRISPR cure HIV? US biotech Excision raises $60m to find out

The Challenges and Promise of CAR T-Cell Therapy in Oncology

Webinars

Stay Connected